{"id":205536,"date":"2026-04-24T11:19:00","date_gmt":"2026-04-24T15:19:00","guid":{"rendered":"https:\/\/testing.news-you-need.com\/index.php\/2026\/04\/24\/medtronic-awards-highlight-cybersecurity-strength-and-ai-device-growth-potential\/"},"modified":"2026-04-24T13:00:18","modified_gmt":"2026-04-24T17:00:18","slug":"medtronic-awards-highlight-cybersecurity-strength-and-ai-device-growth-potential","status":"publish","type":"post","link":"https:\/\/testing.news-you-need.com\/index.php\/2026\/04\/24\/medtronic-awards-highlight-cybersecurity-strength-and-ai-device-growth-potential\/","title":{"rendered":"Medtronic Awards Highlight Cybersecurity Strength And AI Device Growth Potential"},"content":{"rendered":"

Medtronic Awards Highlight Cybersecurity Strength And AI Device Growth Potential<\/a><\/p>\n

https:\/\/simplywall.st\/stocks\/us\/healthcare\/nyse-mdt\/medtronic\/news\/medtronic-awards-highlight-cybersecurity-strength-and-ai-dev<\/a><\/p>\n

Publish Date: 2026-04-24 11:19:00<\/a><\/p>\n

Source Domain: simplywall.st<\/a><\/p>\n

Author: <\/a><\/p>\n

Using an unordered list, summarize the following article with between 4 and 8 key points. Medtronic (NYSE:MDT) received the Super Global ORBIE Award through its VP & CISO, Dr. Stephanie Franklin-Thomas, highlighting the company\u2019s focus on cybersecurity and digital resilience. The company\u2019s Altaviva device was honored with a 2026 Edison Award for best in class innovation in urinary urge incontinence care. These awards arrive alongside continued commercialization of AI driven cardiovascular solutions, adding fresh context to Medtronic\u2019s broader device portfolio. Medtronic\u2019s recent recognition in cybersecurity and medical device design comes as the stock trades around $83.79, with a value score of 5 and a mixed return profile that includes a 2.6% gain over 1 year and a 25.8% decline over 5 years. For investors tracking NYSE:MDT, these awards relate to the company\u2019s positioning across both digital security and treatment categories that extend beyond its larger cardiovascular and neurosurgery platforms. For a long term thesis, these developments may interest readers who focus on brand strength, product depth, and trust in connected medical devices rather than only near term share price moves. Recognition for cybersecurity leadership, paired with awards for devices like Altaviva and ongoing AI work in cardiovascular care, may inform how clinicians, patients, and partners view Medtronic\u2019s role in future care pathways. Stay updated on the most important news stories for Medtronic by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Medtronic. NYSE:MDT Earnings & Revenue Growth as at Apr 2026 We’ve flagged 0 risks for Medtronic. See which could impact your investment. Quick Assessment \u2705 Price vs Analyst Target: The US$83.79 share price sits about 22% below the US$108 analyst target, with a published range of US$90 to US$121. \u2696\ufe0f Simply Wall St Valuation: Shares are described as trading close to estimated fair value, with a value score of 5. \u274c Recent Momentum: The 30 day return is about a 3.2% decline, signaling soft short term sentiment. There is only one way to know the right time to buy, sell or hold Medtronic. Head to Simply Wall St’s
\ncompany report for the latest analysis of Medtronic’s Fair Value. Key Considerations \ud83d\udcca Recognition for cybersecurity leadership and device design may support investor views on trust, brand quality, and adoption of connected devices. \ud83d\udcca Watch how AI driven cardiovascular solutions translate into revenue, earnings per share, and any updates to analyst targets or P\/E relative to the 23.3x level. \u26a0\ufe0f Awards do not guarantee commercial success, so monitor execution risk around product rollouts and clinician uptake of new platforms. Dig Deeper For the full picture including more risks and rewards, check out the
\ncomplete Medtronic analysis. Alternatively, you can visit the
\ncommunity page for Medtronic to see how other investors believe this latest news will impact the company’s narrative. This article by Simply Wall St is general in nature. We provide commentary based on historical data
\n and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
\n financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
\n Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
\n Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe’ve created the ultimate portfolio companion for stock investors, and it’s free.\u2022 Connect an unlimited number of Portfolios and see your total in one currency\u2022 Be alerted to new Warning Signs or Risks via email or mobile\u2022 Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
<\/p>\n","protected":false},"excerpt":{"rendered":"

Medtronic Awards Highlight Cybersecurity Strength And AI Device Growth Potential https:\/\/simplywall.st\/stocks\/us\/healthcare\/nyse-mdt\/medtronic\/news\/medtronic-awards-highlight-cybersecurity-strength-and-ai-dev Publish Date: 2026-04-24 11:19:00…<\/p>\n","protected":false},"author":1,"featured_media":205537,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/images.simplywall.st\/asset\/company-cover\/31348-main-header\/1756253047734","fifu_image_alt":"","footnotes":""},"categories":[15],"tags":[26,24],"class_list":["post-205536","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cybersecurity","tag-ai","tag-cybersecurity"],"_links":{"self":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/205536"}],"collection":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=205536"}],"version-history":[{"count":1,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/205536\/revisions"}],"predecessor-version":[{"id":205538,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/205536\/revisions\/205538"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/205537"}],"wp:attachment":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=205536"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=205536"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=205536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}